nanoFIS 2017 - Functional Integrated nanoSystems
22 - 24 November 2017
Mauro Ferrari, Prof. Dr.
Ernest Cockrell Jr. Presidential Distinguished Chair, President & CEO, Houston Methodist Research Institute, Director, Institute for Academic Medicine at Houston Methodist Hospital, Executive Vice President, Houston Methodist Hospital System, Weill Cornell Medical College, Senior Associate Dean and Professor of Medicine, New York (USA)
Post - Nanomedicine
Rajagopal Ramesh, Ph.D.
University of Oklahoma Health Sciences Center, Jim and Christy Everest Endowed Chair in Cancer Developmental Therapeutics, Experimental Therapeutics and Translational Cancer Medicine, Small Animal Bioluminescence Imaging Core, Stanton L. Young Biomedical Research Center (USA)
Tumor-Targeted Therapy against an RNA-binding Protein for Lung Cancer
Mukhles Sowwan, Prof. PhD.
Okinawa Institute of Science and Technology, Director of Nanoparticles by Design for Nanotechnology and Biomedical Applications (Japan)
Smart Gas Sensing Platform for Biomedical Applications
María Blanco-Prieto, Prof. Dr.
University of Navarra, Department of Pharmacy and Pharmaceutical Technology, Pamplona (Spain)
Nanomedicines to treat Brain Diseases
Gerrit Borchard, Prof. Dr.
Université de Genève, Section des Sciences Pharmaceutiques, President of Swiss Academy of Pharmaceutical Sciences (SAPhS) (Switzerland)
Physicochemical Properties of Nanomedicines: What matters and why?
Christian Hellmich, Univ.-Prof. DI Dr.
Vienna University of Technology (TU Wien), Institute for Mechanics of Materials and Structures (Austria)
Engineering Sciences Supporting Regenerative BioMedicine: Recent Accomplishments
Peter Lieberzeit, Univ. Prof. Mag. Dr.
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry, Chemical Sensors and Optical Molecular Spectroscopy (Austria)
Molecularly Imprinted Polymers and their Composites in Detecting Clinically relevant Species
Stefan Mühlebach, Prof. Dr.
University of Basel, Department of Pharmaceutical Sciences, Vifor Fresenius Medical Care Renal Pharma Ltd., Vice-President of SAPhS, Head of Lygature NBCD working group (Switzerland)
IV Iron Nanocolloidals: Why Therapeutic Equivalence Matters
Roland Pohle, Dr.
Siemens Corporate Research, Munich (Germany)
Towards a Mobile Breath Analysis Platform: an Update on the Sniffphone Project
Adriele Prina-Mello, Dr.
Trinity College Dublin, Faculty of Health Sciences, School of Medicine (Ireland)
Cancer Theranostics: a Translational Nanomedicine Perspective
Avi Schröder, Prof. PhD.
Technion – Israel Institute of Technology, Department of Chemical Engineering, Laboratory for Targeted Drug Delivery and Personalized Medicine Technologies (Israel)
Personalized Nanomedicines: Cancer and other Diseases
Alejandro Sosnik, Prof. PhD.
Technion – Israel Institute of Technology, Materials Science and Engineering, Laboratory of Pharmaceutical Nanomaterial Science (Israel)
Polymeric Micelles Stabilized by Drug-Compatible Chemical Pathways
Dimitrios Stamatialis, Prof. Dr.
University of Twente, MIRA institute of Biomedical Engineering and Technical Medicine, Faculty of Science and Technology, Department of Biomaterials Science and Technology (The Netherlands)
Nanoporous Membrane Systems for Pancreatic Islet Macroencapsulation